We detected the expression of several markers of cell stemness, such as CD44, CD133, OCT4, Nanog, and KLF4, to test whether the effect of Arl4c on promoting drug resistance in pancreatic cancer is attributed to its role in regulating cell stemness. This evidence concerns the gene POU5F1 and familial pancreatic carcinoma.